Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1230-1239

  Steinberg, Helmut O ^a,b   Tarshoby, Manal ^a   Monestel, Robert ^a   Hook, Ginger ^a   Cronin, Jessica ^a   Johnson, Ann ^a   Bayazeed, Basel ^a,b   Baron, Alain D ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

Author keywords

Arterial blood pressure; Atherosclerosis; Insulin resistance; Leg blood flow; Nitric oxide

Indexed keywords

FATTY ACID; HEPARIN; INSULIN; INTRALIPID; METHACHOLINE CHLORIDE; NITROPRUSSIDE SODIUM; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOINSULINEMIA; LEG BLOOD FLOW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030921893     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119636     Document Type: Article

References (15)

1. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. J. Clin. Invest. 85:1844-1852.
2. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J. Clin. Invest. 94:1172-1179.
3. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1992. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 41:1076-1083.
4. Steinberg, H.O., H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A.D. Baron. 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97: 2601-2610.
5. Davda, R.K., K.T. Stepniakowski, G. Lu, M.E. Ullian, T.L. Goodfriend, and B.M. Egan. 1995. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension, 26:764-770.
6. Bruce, R., I. Godsland, C. Walton, D. Crook, and V. Wynn. 1994. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism. 43:1275-1281.
7. Swislocki, A.L.M., Y.-D.I. Chen, A. Goley, M.-O. Chang, and G.M. Reaven. 1987. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 30:622-626.
8. Baron, A.D., G. Brechtel, P. Wallace, and S.V. Edelman. 1988. Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255:E769-E774.
9. Baron, A.D., O.G. Kolterman, J. Bell, L.J. Mandarino, and J.M. Oleffsky. 1985. Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J. Clin. Invest. 76:1782-1788.
10. Novak, M. 1965. Colorimetric ultramicro method for the determination of free fatty acids. J. Lipid Res. 6:431-433.
11. Reaven, G.M. 1994. Syndrome X: 6 years later. J. Intern. Med. 236 (Suppl. 736): 13-22.
12. Bonadonna, R.C., K. Zych, C. Boni, E. Ferrannini, and R.A. DeFronzo. 1989. Time dependence of the interaction between lipid and glucose in humans. Am. J. Physiol. 257:E49-E56.
13. Grekin, R.J., A.P. Vollmer, and R.S. Sider. 1995. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension. 26:193-198.
14. Stepniakowski, K.T., T.L. Goodfriend, and B.M. Egan. 1995. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 25 (4):774-778.
15. Lloyd-Jones, D.M., and K.D. Bloch. 1996. The vascular biology of nitric oxide and its role in atherogenesis. Ann. Rev. Med. 47:365-375.